Magnolia Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
2,175
-440
-17% -$151K 0.54% 33
2026
Q1
$920K Buy
2,615
+440
+20% +$157K 0.62% 33
2025
Q4
$712K Buy
2,175
+75
+4% +$23.8K 0.53% 33
2025
Q3
$593K Hold
2,100
0.46% 43
2025
Q2
$586K Hold
2,100
0.47% 44
2025
Q1
$654K Hold
2,100
0.56% 36
2024
Q4
$547K Hold
2,100
0.43% 45
2024
Q3
$677K Hold
2,100
0.54% 41
2024
Q2
$656K Hold
2,100
0.55% 38
2024
Q1
$597K Hold
2,100
0.51% 44
2023
Q4
$605K Hold
2,100
0.55% 37
2023
Q3
$564K Hold
2,100
0.55% 41
2023
Q2
$466K Hold
2,100
0.42% 51
2023
Q1
$508K Hold
2,100
0.48% 46
2022
Q4
$552K Hold
2,100
0.54% 45
2022
Q3
$473K Hold
2,100
0.49% 46
2022
Q2
$511K Hold
2,100
0.5% 42
2022
Q1
$508K Hold
2,100
0.42% 48
2021
Q4
$472K Hold
2,100
0.37% 51
2021
Q3
$447K Buy
+2,100
New +$483K 0.39% 51

Other funds holding AMGN

Magnolia Capital Management's AMGN Position: Q2 2026 in Review

Magnolia Capital Management reduced its Amgen (AMGN) stake by 17% in Q2 2026, selling an estimated $151K and leaving 2,175 shares worth $788K. The position accounts for 0.54% of the portfolio, ranked #33.

Magnolia Capital Management first reported a position in AMGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $920K in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Magnolia Capital Management held 2,175 shares of Amgen worth $788K as of Q2 2026.
  • Magnolia Capital Management sold 440 Amgen shares in Q2 2026, an estimated $151K.
  • Amgen made up 0.54% of Magnolia Capital Management's portfolio in Q2 2026, its #33 holding.
  • Magnolia Capital Management first reported a position in Amgen in Q3 2021 and has held it in 20 quarters since.
  • Magnolia Capital Management's Amgen position peaked at $920K in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Magnolia Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.